title: Gadd45b and Gadd45g are important for anti-tumor immune responses.
abstract: An effective Th1 type cell-mediated immune response against cancer cells is critical in limiting cancer progression. Gadd45b, a signaling molecule highly up-regulated during Th1 type responses, is studied for its role in limiting tumor growth. Mouse B16 melanoma cells implanted into Gadd45b(-/-) mice grew faster than those in WT or Gadd45b(+/-) littermate controls. The defect of Gadd45b(-/-) mice in tumor immunosurveillance was attributed to the reduced expression of IFN-gamma, granzyme B, and CCR5 in Gadd45b(-/-) CD8(+) T cells at the tumor site. Activation of p38 MAP kinase, but not ERK or JNK, by either TCR-stimuli or IL-12 and IL-18 is diminished in Gadd45b(-/-) CD8(+) T cells, resulting in reduced production of IFN-gamma. In addition, mRNA of T-bet and Eomes were reduced in Gadd45b(-/-) CD8(+) T cells, supporting a critical role of Gadd45b in shaping the Th1 fate. More importantly, the tumor vaccination, which is effective in WT mice, failed in Gadd45b/Gadd45g doubly deficient mice. Collectively, these data demonstrate that members of the Gadd45 gene family are important for anti-tumor immune responses.
authors.affiliation: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
authors.forename: Songguang
authors.initials: S
authors.lastname: Ju
authors.forename: Yibei
authors.initials: Y
authors.lastname: Zhu
authors.forename: Lin
authors.initials: L
authors.lastname: Liu
authors.forename: Shao
authors.initials: S
authors.lastname: Dai
authors.forename: Changyou
authors.initials: C
authors.lastname: Li
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Chen
authors.forename: Yukai
authors.initials: Y
authors.lastname: He
authors.forename: Xueguang
authors.initials: X
authors.lastname: Zhang
authors.forename: Binfeng
authors.initials: B
authors.lastname: Lu
mesh_terms: D000818:Animals; D000943:Antigens, Differentiation / Q000235:genetics / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002352:Carrier Proteins / Q000235:genetics / Q000276:immunology*; D007157:Immunologic Surveillance / Q000276:immunology*; D007371:Interferon-gamma / Q000276:immunology; D047908:Intracellular Signaling Peptides and Proteins; D008546:Melanoma, Experimental / Q000235:genetics / Q000276:immunology*; D051379:Mice; D018345:Mice, Knockout; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000276:immunology*; D000097642:GADD45 Proteins
chemical_list: D000943:Antigens, Differentiation; D002352:Carrier Proteins; D007371:Interferon-gamma; D047908:Intracellular Signaling Peptides and Proteins; C490125:Gadd45b protein, mouse; D000097642:GADD45 Proteins; C121373:Gadd45g protein, mouse
references.citation: Curr Opin Immunol. 1994 Jun;6(3):458-66
references.pmid: 7917115
references.citation: J Immunol. 2003 Aug 1;171(3):1232-9
references.pmid: 12874210
references.citation: Nat Immunol. 2001 Feb;2(2):157-64
references.pmid: 11175814
references.citation: EMBO J. 2004 Apr 7;23(7):1576-86
references.pmid: 15044949
references.citation: J Immunol. 1986 Apr 1;136(7):2348-57
references.pmid: 2419430
references.citation: J Exp Med. 2005 Apr 18;201(8):1257-68
references.pmid: 15824085
references.citation: J Immunol. 2005 Jan 15;174(2):898-906
references.pmid: 15634912
references.citation: Am J Pathol. 2003 Jun;162(6):1961-74
references.pmid: 12759252
references.citation: Cell. 2000 Mar 17;100(6):655-69
references.pmid: 10761931
references.citation: J Cell Physiol. 2002 Sep;192(3):327-38
references.pmid: 12124778
references.citation: Clin Cancer Res. 1999 Jan;5(1):9-16
references.pmid: 9918197
references.citation: Science. 2003 Nov 7;302(5647):1041-3
references.pmid: 14605368
references.citation: Immunol Rev. 2006 Oct;213:131-45
references.pmid: 16972901
references.citation: Cancer Res. 2004 Jan 15;64(2):452-5
references.pmid: 14744755
references.citation: J Exp Med. 2005 Nov 21;202(10):1341-7
references.pmid: 16287712
references.citation: Nat Immunol. 2004 Jan;5(1):38-44
references.pmid: 14691480
references.citation: Gut. 2007 Nov;56(11):1572-8
references.pmid: 17566017
references.citation: Nat Immunol. 2002 Nov;3(11):991-8
references.pmid: 12407406
references.citation: Science. 2006 Sep 29;313(5795):1960-4
references.pmid: 17008531
references.citation: Immunity. 2001 May;14(5):583-90
references.pmid: 11371360
references.citation: Adv Immunol. 2007;96:41-101
references.pmid: 17981204
references.citation: J Exp Med. 2003 Aug 4;198(3):433-42
references.pmid: 12900519
references.citation: Clin Cancer Res. 2007 Aug 15;13(16):4677-85
references.pmid: 17699845
references.citation: J Immunol. 2006 Dec 1;177(11):7515-9
references.pmid: 17114419
references.citation: Clin Cancer Res. 2005 Sep 15;11(18):6442-9
references.pmid: 16166418
references.citation: J Exp Med. 2002 Sep 2;196(5):619-28
references.pmid: 12208877